The Front Room — a clinical regulatory commons
RSS
← Back to The Docket
AUG 22 2026
APPROVED · 38 DAYS AGO

Revance — RHA Redensity Eye (hyaluronic acid filler)

for Correction of moderate to severe tissue volume deficiencies in the infraorbital region (undereye hollows)

NDA

FDA approves RHA Redensity Eye hyaluronic acid filler for correction of moderate to severe tissue volume deficiencies in the infraorbital region.

About

RHA Redensity Eye is a hyaluronic acid filler, a gel-like substance that is injected to add volume and smooth the skin. It is designed to be flexible and resilient, integrating with the body's natural tissues. This treatment aims to restore a more rested appearance by filling in the hollows under the eyes.